KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Emergent BioSolutions (EBS) Non-Current Debt (2016 - 2026)

Emergent BioSolutions has reported Non-Current Debt over the past 17 years, most recently at $573.6 million for Q1 2026.

  • For Q1 2026, Non-Current Debt fell 13.84% year-over-year to $573.6 million; the TTM value through Mar 2026 reached $573.6 million, down 13.84%, while the annual FY2025 figure was $572.1 million, 13.8% down from the prior year.
  • Non-Current Debt for Q1 2026 was $573.6 million at Emergent BioSolutions, roughly flat from $572.1 million in the prior quarter.
  • Over five years, Non-Current Debt peaked at $1.0 billion in Q3 2022 and troughed at $446.5 million in Q4 2023.
  • A 5-year average of $601.6 million and a median of $573.6 million in 2026 define the central range for Non-Current Debt.
  • Biggest five-year swings in Non-Current Debt: plummeted 56.57% in 2023 and later surged 49.4% in 2025.
  • Year by year, Non-Current Debt stood at $448.5 million in 2022, then fell by 0.45% to $446.5 million in 2023, then skyrocketed by 48.65% to $663.7 million in 2024, then fell by 13.8% to $572.1 million in 2025, then increased by 0.26% to $573.6 million in 2026.
  • Business Quant data shows Non-Current Debt for EBS at $573.6 million in Q1 2026, $572.1 million in Q4 2025, and $663.1 million in Q3 2025.